Co-Occurrence of Psoriasis and Rheumatic Diseases Common

FRIDAY, Aug. 11, 2023 (HealthDay News) -- Psoriasis is associated with rheumatic diseases, according to a study published online Aug. 5 in the Journal of the American Academy of Dermatology.
Mimi Chung, from the University of California in San Francisco, and colleagues conducted a cross-sectional cohort study using the U.S.-based racially and ethnically diverse All of Us national database to examine the association between psoriasis and rheumatic diseases. Rheumatic diseases of interest were identified in two cohorts: a psoriasis group with two or more diagnoses of psoriasis and a control group without a diagnosis of psoriasis.
The researchers identified a significant association for psoriasis with psoriatic arthritis (PsA), osteoarthritis, gout, fibromyalgia, rheumatoid arthritis, ankylosing spondylitis, Sjogren syndrome, and systemic sclerosis. Due to clinical overlap between PsA and other rheumatic conditions, the percentage of PsA patients diagnosed with concomitant diseases was examined; common codiagnosis included osteoarthritis, rheumatoid arthritis, and fibromyalgia (47.6, 15.1, and 12.7 percent, respectively).
"Co-occurrence of psoriasis and rheumatic diagnoses may in part be due to common underlying mechanisms such as higher body mass index," the authors write. "Of note, however, [psoriasis] was associated with an increased odds of rheumatic disease compared to controls even after adjustment for body mass index."
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Mean Monthly BP Increased Among U.S. Adults During COVID-19
MONDAY, March 7, 2022 (HealthDay News) -- Among adults in the United States,...
One-Third of Pregnant Women Report Mental Distress During Pandemic
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Nearly one in three pregnant women...
Cancer Patients Give Telemedicine High Marks
WEDNESDAY, May 10, 2023 (HealthDay News) -- Cancer patients report better...
Therapeutic Value of Drugs Lower for Supplemental Versus First Indications
FRIDAY, July 7, 2023 (HealthDay News) -- For drugs approved in the United States...
